KTTAW
Income statement / Annual
Last year (2024), Pasithea Therapeutics Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Pasithea Therapeutics Corp.'s net income was -$13.90 B.
See Pasithea Therapeutics Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$486,559.00 |
$15,062.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$648,454.00
|
$113,195.00
|
$17,275.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$648,454.00
|
$373,364.00
|
-$2,213.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0.77
|
-0.15
|
0
|
| Research and Development Expenses |
$7.20 B
|
$8.10 M
|
$2.67 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$7.88 B
|
$9.92 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
-$7.87 B
|
$2.60 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.05 B
|
$7.88 M
|
$12.52 M
|
$4.51 M
|
$40,984.00
|
| Other Expenses |
$0.00
|
$0.00
|
$44,723.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$14.25 B
|
$15.98 M
|
$15.19 M
|
$4.51 M
|
$40,984.00
|
| Cost And Expenses |
$0.00
|
$15.98 M
|
$15.30 M
|
$4.52 M
|
$40,984.00
|
| Interest Income |
$0.00
|
$0.00
|
$102.00
|
$508.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$102.00
|
$508.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$648,454.00
|
$5,094.00
|
$1,379.00
|
$61,476.00
|
| EBITDA |
-$14.25 B |
-$15.33 M |
-$12.58 M |
-$4.51 M |
$0.00 |
| EBITDA Ratio |
0
|
0
|
-25.86
|
-299.17
|
0
|
| Operating Income Ratio |
0
|
0
|
-30.45
|
-299.26
|
0
|
| Total Other Income/Expenses Net |
$345.38 M
|
$471,613.00
|
$861,086.00
|
$2.33 M
|
-$4.00
|
| Income Before Tax |
-$13.90 B
|
-$15.51 M
|
-$13.94 M
|
-$2.17 M
|
-$40,984.00
|
| Income Before Tax Ratio |
0
|
0
|
-28.64
|
-144.3
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$879,971.00
|
$508.00
|
-$61,476.00
|
| Net Income |
-$13.90 B
|
-$15.96 M
|
-$13.06 M
|
-$2.17 M
|
-$40,984.00
|
| Net Income Ratio |
0
|
0
|
-26.83
|
-144.34
|
0
|
| EPS |
-12685.72 |
-12.65 |
-10.34 |
-1.89 |
-0.0595 |
| EPS Diluted |
-12685.72 |
-13.01 |
-10.34 |
-1.89 |
-0.0595 |
| Weighted Average Shares Out |
$1.10 M
|
$1.26 M
|
$1.26 M
|
$1.15 M
|
$688,918.00
|
| Weighted Average Shares Out Diluted |
$1.10 M
|
$1.23 M
|
$1.26 M
|
$1.15 M
|
$688,918.00
|
| Link |
|
|
|
|
|
